1.           Introduction  15

1.1         Scope of the Study. 15

1.2         The Insight Partners Research Report Guidance. 15

1.3         Market Segmentation. 17

1.3.1        Europe Epirubicin Market – By Dosage. 19

1.3.2        Europe Epirubicin Market – By Application. 19

1.3.3        Europe Epirubicin Market – By Distribution Channel 19

1.3.4        Europe Epirubicin Market – By Country. 20

2.           Key Takeaways  21

3.        Research Methodology  24

3.1         Coverage. 26

3.2         Secondary Research. 26

3.3         Primary Research. 27

4.           Europe Epirubicin Market – Market Landscape  28

4.1         Overview.. 28

4.2         Europe PEST Analysis. 29

4.3         Experts Opinion. 30

5.           Europe Epirubicin Market– Key Market Dynamics  31

5.1         Market Drivers. 31

5.1.1        Rising Prevalence of Cancer 31

5.1.2        Increasing Awareness Regarding Cancer 31

5.2         Market Restraints. 32

5.2.1        Elevated Risk of Adverse Effects due to Epirubicin. 32

5.3         Future Trends. 32

5.3.1        Increase in Number of Cancer Research Programs. 32

5.4         Impact Analysis. 33

6.           Epirubicin Market– Europe Analysis  34

6.1         Europe Epirubicin Market Revenue Forecasts and Analysis. 34

7.           Europe Epirubicin Market Analysis – By Dosage  36

7.1         Overview.. 36

7.2         Europe Epirubicin Market, by Dosage, 2022 & 2028 (%) 36

7.3         10mg/Vial 37

7.3.1        Overview.. 37

7.3.2        10mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand) 37

7.4         50mg/Vial 38

7.4.1        Overview.. 38

7.4.2        50mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand) 38

7.5         100mg/Vial 39

7.5.1        Overview.. 39

7.5.2        100mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand) 39

7.6         200mg/Vial 40

7.6.1        Overview.. 40

7.6.2        200 Mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand) 40

8.           Europe Epirubicin Market Analysis – By Application  41

8.1         Overview.. 41

8.2         Europe Epirubicin Market, by Application, 2022 & 2028 (%) 41

8.3         Breast Cancer 42

8.3.1        Overview.. 42

8.3.2        Breast Cancer Market Revenue and Forecast to 2028 (US$ Thousand) 42

8.4         Liver Cancer 43

8.4.1        Overview.. 43

8.4.2        Liver Cancer Market Revenue and Forecast to 2028 (US$ Thousand) 44

8.5         Bladder Cancer 45

8.5.1        Overview.. 45

8.5.2        Bladder Cancer Market Revenue and Forecast to 2028 (US$ Thousand) 45

8.6         Others. 46

8.6.1        Overview.. 46

8.6.2        Others Cancer Market Revenue and Forecast to 2028 (US$ Thousand) 46

9.           Europe Epirubicin Market Analysis – By Distribution Channel 47

9.1         Overview.. 47

9.2         Europe Epirubicin Market, by Distribution Channel, 2022 & 2028 (%) 47

9.3         Hospital Pharmacies. 48

9.3.1        Overview.. 48

9.3.2        Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand) 48

9.4         Retail Pharmacies. 49

9.4.1        Overview.. 49

9.4.2        Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand) 49

9.5         Online Pharmacies. 50

9.5.1        Overview.. 50

9.5.2        Online Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand) 51

10.        Europe Epirubicin Market – Country Analysis  52

10.1      Overview.. 52

10.1.1     Europe: Epirubicin Market, by Country, 2022 & 2028 (%) 54

10.1.1.1       Germany: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 54

10.1.1.1.1       Overview.. 54

10.1.1.1.2       Germany: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 56

10.1.1.1.3       Germany: Epirubicin Market, by Dosage, 2019–2028 (US$ Thousand) 57

10.1.1.1.4       Germany: Epirubicin Market, by Application, 2019–2028 (US$ Thousand) 57

10.1.1.1.5       Germany: Epirubicin Market, by Distribution Channel, 2019–2028 (US$ Thousand) 58

10.1.1.2       UK: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 59

10.1.1.2.1       Overview.. 59

10.1.1.2.2       UK: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 59

10.1.1.2.3       UK: Epirubicin Market, by Dosage, 2019–2028 (US$ Thousand) 60

10.1.1.2.4       UK: Epirubicin Market, by Application, 2019–2028 (US$ Thousand) 61

10.1.1.2.5       UK: Epirubicin Market, by Distribution Channel, 2019–2028 (US$ Thousand) 62

10.1.1.3       France: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 63

10.1.1.3.1       Overview.. 63

10.1.1.3.2       France: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 64

10.1.1.3.3       France: Epirubicin Market, by Dosage, 2019–2028 (US$ Thousand) 65

10.1.1.3.4       France: Epirubicin Market, by Application, 2019–2028 (US$ Thousand) 65

10.1.1.3.5       France: Epirubicin Market, by Distribution Channel, 2019–2028 (US$ Thousand) 66

10.1.1.4       Italy: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 67

10.1.1.4.1       Overview.. 67

10.1.1.4.2       Italy: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 68

10.1.1.4.3       Italy: Epirubicin Market, by Dosage, 2019–2028 (US$ Thousand) 69

10.1.1.4.4       Italy: Epirubicin Market, by Application, 2019–2028 (US$ Thousand) 69

10.1.1.4.5       Italy: Epirubicin Market, by Distribution Channel, 2019–2028 (US$ Thousand) 70

10.1.1.5       Spain: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 71

10.1.1.5.1       Overview.. 71

10.1.1.5.2       Spain: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 72

10.1.1.5.3       Spain: Epirubicin Market, by Dosage, 2019–2028 (US$ Thousand) 73

10.1.1.5.4       Spain: Epirubicin Market, by Application, 2019–2028 (US$ Thousand) 73

10.1.1.5.5       Spain: Epirubicin Market, by Distribution Channel, 2019–2028 (US$ Thousand) 74

10.1.1.6       Rest of Europe: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 75

10.1.1.6.1       Overview.. 75

10.1.1.6.2       Rest of Europe: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 75

10.1.1.6.3       Rest of Europe: Epirubicin Market, by Dosage, 2019–2028 (US$ Thousand) 76

10.1.1.6.4       Rest of Europe: Epirubicin Market, by Application, 2019–2028 (US$ Thousand) 77

10.1.1.6.5       Rest of Europe: Epirubicin Market, by Distribution Channel, 2019–2028 (US$ Thousand) 78

11.        Industry Landscape  79

11.1      Overview.. 79

11.2      Growth Strategies. 79

11.2.1     Overview.. 79

12.        Company Profiles  80

12.1      Pfizer Inc. 80

12.1.1     Key Facts. 80

12.1.2     Business Description. 80

12.1.3     Products and Services. 81

12.1.4     Financial Overview.. 81

12.1.5     SWOT Analysis. 84

12.1.6     Key Developments. 84

12.2      Teva Pharmaceutical Industries Ltd. 85

12.2.1     Key Facts. 85

12.2.2     Business Description. 85

12.2.3     Products and Services. 86

12.2.4     Financial Overview.. 86

12.2.5     SWOT Analysis. 88

12.2.6     Key Developments. 88

12.3      Salius Pharma Pvt Ltd. 89

12.3.1     Key Facts. 89

12.3.2     Business Description. 89

12.3.3     Products and Services. 89

12.3.4     Financial Overview.. 90

12.3.5     SWOT Analysis. 90

12.3.6     Key Developments. 90

12.4      Mylan N.V. 91

12.4.1     Key Facts. 91

12.4.2     Business Description. 91

12.4.3     Products and Services. 92

12.4.4     Financial Overview.. 92

12.4.5     SWOT Analysis. 94

12.4.6     Key Developments. 94

12.5      Hikma Pharmaceuticals PLC. 95

12.5.1     Key Facts. 95

12.5.2     Business Description. 95

12.5.3     Products and Services. 95

12.5.4     Financial Overview.. 96

12.5.5     SWOT Analysis. 98

12.5.6     Key Developments. 99

12.6      Fresenius Kabi AG.. 100

12.6.1     Key Facts. 100

12.6.2     Business Description. 100

12.6.3     Products and Services. 101

12.6.4     Financial Overview.. 101

12.6.5     SWOT Analysis. 104

12.6.6     Key Developments. 104

13.        Appendix  105

13.1      About The Insight Partners. 105

13.2      Glossary of Terms. 105

LIST OF TABLES

Table 1.             Europe Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 35

Table 2.             Incidence, Mortality and Prevalence by cancer site, 2018, Germany. 55

Table 3.             Germany Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (US$ Thousand) 57

Table 4.             Germany: Epirubicin Market, by Application – Revenue and Forecast to 2028 (US$ Thousand) 57

Table 5.             Germany Epirubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand) 58

Table 6.             UK Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (US$ Thousand) 60

Table 7.             UK: Epirubicin Market, by Application – Revenue and Forecast to 2028 (US$ Thousand) 61

Table 8.             UK Epirubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand) 62

Table 9.             Incidence, Mortality and Prevalence by cancer site, 2018, France. 63

Table 10.          France Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (US$ Thousand) 65

Table 11.          France: Epirubicin Market, by Application – Revenue and Forecast to 2028 (US$ Thousand) 65

Table 12.          France Epirubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand) 66

Table 13.          Incidence, Mortality and Prevalence by cancer site, 2018, Italy. 67

Table 14.          Italy Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (US$ Thousand) 69

Table 15.          Italy: Epirubicin Market, by Application – Revenue and Forecast to 2028 (US$ Thousand) 69

Table 16.          Italy Epirubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand) 70

Table 17.          Incidence, Mortality and Prevalence by cancer site, 2018, Spain. 71

Table 18.          Spain Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (US$ Thousand) 73

Table 19.          Spain: Epirubicin Market, by Application – Revenue and Forecast to 2028 (US$ Thousand) 73

Table 20.          Spain Epirubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand) 74

Table 21.          Rest of Europe Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (US$ Thousand) 76

Table 22.          Rest of Europe: Epirubicin Market, by Application – Revenue and Forecast to 2028 (US$ Thousand) 77

Table 23.          Rest of Europe Epirubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand) 78

Table 24.          Recent Growth Strategies. 79

Table 25.          Glossary of Terms. 105

LIST OF FIGURES

Figure 1.           Europe Epirubicin Market Segmentation. 17

Figure 2.           Europe Epirubicin Market, By Country. 18

Figure 3.           Europe Epirubicin Market Overview.. 21

Figure 4.           Europe Epirubicin Market, By Dosage. 22

Figure 5.           Europe Epirubicin Market, By Country. 23

Figure 6.           Europe: PEST Analysis. 29

Figure 7.           Experts Opinion. 30

Figure 8.           Impact Analysis of Drivers and Restraints on Europe Epirubicin Market 33

Figure 9.           Europe Epirubicin Market – Revenue Forecasts and Analysis. 34

Figure 10.        Europe Epirubicin Market, by Dosage, 2022 & 2028 (%) 36

Figure 11.        Europe 10mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand) 37

Figure 12.        Europe 50mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand) 38

Figure 13.        Europe 100mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand) 39

Figure 14.        Europe 200 Mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand) 40

Figure 15.        Europe Epirubicin Market, by Application, 2022 & 2028 (%) 41

Figure 16.        Europe Breast Cancer Market Revenue and Forecast to 2028 (US$ Thousand) 43

Figure 17.        Europe Liver Cancer Market Revenue and Forecast to 2028 (US$ Thousand) 44

Figure 18.        Europe Bladder Cancer Market Revenue and Forecast to 2028 (US$ Thousand) 45

Figure 19.        Europe Others Cancer Market Revenue and Forecast to 2028 (US$ Thousand) 46

Figure 20.        Europe Epirubicin Market, by Distribution Channel, 2022 & 2028 (%) 47

Figure 21.        Europe Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand) 49

Figure 22.        Europe Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand) 50

Figure 23.        Europe Online Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand) 51

Figure 24.        Europe: Epirubicin Market, by Key Country – Revenue (2022) (US$ Thousand) 53

Figure 25.        Europe: Epirubicin Market, by Country, 2022 & 2028 (%) 54

Figure 26.        Germany: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 56

Figure 27.        UK: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 60

Figure 28.        France: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 64

Figure 29.        Italy: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 68

Figure 30.        Spain: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 72

Figure 31.        Rest of Europe: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand) 76